MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate the efficacy of Ivermectin 1% cream (IVM)
associated with Brimonidine 0.33% gel (Br) compared with the association of their respective
vehicles in the treatment of moderate to severe rosacea.